JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 23, 2003; DOI: 10.1124/jpet.103.052944


0022-3565/03/3063-1042-1049$20.00
JPET 306:1042-1049, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.052944v1
306/3/1042    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Néemeth, Z. H.
Right arrow Articles by Haskó, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Néemeth, Z. H.
Right arrow Articles by Haskó, G.

CELLULAR AND MOLECULAR

cDNA Microarray Analysis Reveals a Nuclear Factor-{kappa}B-Independent Regulation of Macrophage Function by Adenosine

Zoltán H. Néemeth, S. Joseph Leibovich, Edwin A. Deitch, E. Sylvester Vizi, Csaba Szabó, and György Haskó

Departments of Surgery (Z.H.N., E.A.D., C.S., G.H.) and Cell Biology and Molecular Medicine (S.J.L.), University of Medicine and Dentistry-New Jersey Medical School, Newark, New Jersey; Department of Pharmacology (E.S.V., G.H.), Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; and Institute of Human Physiology and Clinical Experimental Research (C.S.), Semmelweis University of Medicine, Budapest, Hungary

Adenosine is released into the extracellular space from nerve terminals and cells subjected to ischemic stress. This nucleoside modulates a plethora of cellular functions via occupancy of specific receptors. Adenosine is also an important endogenous regulator of macrophage function, because it suppresses the production of a number of proinflammatory cytokines by these cells. However, the mechanisms of this anti-inflammatory effect have not been well characterized. We hypothesized that adenosine may exert some of its anti-inflammatory effects by decreasing activation of the transcription factor nuclear factor-{kappa}B (NF-{kappa}B), because gene expression of most of the proinflammatory cytokines inhibited by adenosine is dependent on NF-{kappa}B activation. Using bacterial lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages, we found that adenosine as well as adenosine receptor agonists decreased the production of tumor necrosis factor (TNF)-{alpha}, a typical NF-{kappa}B-regulated cytokine. This effect of adenosine was not due to an action on the process of TNF-{alpha} release, because adenosine suppressed also the intracellular levels of TNF-{alpha}. However, cDNA microarray analysis revealed that mRNA levels of neither TNF-{alpha} nor other cytokines were altered by adenosine in either LPS-activated or quiescent macrophages. In addition, although LPS induced expression of a number of other, noncytokine genes, including the adenosine A2b receptor, adenosine did not affect the expression of these genes. Furthermore, adenosine as well as adenosine receptor agonists failed to decrease LPS-induced NF-{kappa}B DNA binding, NF-{kappa}B promoter activity, p65 nuclear translocation, and inhibitory {kappa}B degradation. Together, our results suggest that the anti-inflammatory effects of adenosine are independent of NF-{kappa}B.


Received April 10, 2003; accepted May 15, 2003.

Address correspondence to: Dr. György Haskó, Department of Surgery, University of Medicine and Dentistry-New Jersey Medical School, 185 South Orange Ave., University Heights, Newark, NJ 07103. E-mail: haskoge{at}umdnj.edu




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
G. Hasko and P. Pacher
A2A receptors in inflammation and injury: lessons learned from transgenic animals
J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich
Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors
Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Csoka, Z. H. Nemeth, L. Virag, P. Gergely, S. J. Leibovich, P. Pacher, C.-X. Sun, M. R. Blackburn, E. S. Vizi, E. A. Deitch, et al.
A2A adenosine receptors and C/EBP{beta} are crucially required for IL-10 production by macrophages exposed to Escherichia coli
Blood, October 1, 2007; 110(7): 2685 - 2695.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Haschemi, O. Wagner, R. Marculescu, B. Wegiel, S. C. Robson, N. Gagliani, D. Gallo, J.-F. Chen, F. H. Bach, and L. E. Otterbein
Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages
J. Immunol., May 1, 2007; 178(9): 5921 - 5929.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Morello, K. Ito, S. Yamamura, K.-Y. Lee, E. Jazrawi, P. DeSouza, P. Barnes, C. Cicala, and I. M. Adcock
IL-1beta and TNF-{alpha} Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-{kappa}B Binding to the Proximal Promoter
J. Immunol., November 15, 2006; 177(10): 7173 - 7183.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. C. Cavalcante, M. V. Castro, A. R. F. Barreto, G. W. Sullivan, M. Vale, P. R. C. Almeida, J. Linden, J. M. Rieger, F. Q. Cunha, R. L. Guerrant, et al.
Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis.
Infect. Immun., May 1, 2006; 74(5): 2606 - 2612.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. H. Nemeth, B. Csoka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Hasko
Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis
J. Immunol., May 1, 2006; 176(9): 5616 - 5626.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Martin, S. C. Pingle, D. M. Hallam, L. P. Rybak, and V. Ramkumar
Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor-{alpha} Release by Reducing Calcium-Dependent Activation of Nuclear Factor-{kappa}B and Extracellular Signal-Regulated Kinase 1/2
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 71 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. H. Nemeth, C. S. Lutz, B. Csoka, E. A. Deitch, S. J. Leibovich, W. C. Gause, M. Tone, P. Pacher, E. S. Vizi, and G. Hasko
Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism
J. Immunol., December 15, 2005; 175(12): 8260 - 8270.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.